Armistice Capital’s Co-Diagnostics CODX Stock Holding History
Bought
Maintained
Sold
Other funds holding CODX
Armistice Capital's CODX Position: Q3 2026 in Review
Armistice Capital sold out of Co-Diagnostics (CODX) in Q3 2026, closing a stake of 236,000 shares — an estimated $732K sold.
Armistice Capital first reported a position in CODX in Q2 2026 and held it in 1 quarter. The position peaked at $732K in Q2 2026. 24 funds tracked by Wall St. Rank hold CODX as of Q3 2026.
- Armistice Capital reported no remaining Co-Diagnostics position as of Q3 2026 after selling out during the quarter.
- Armistice Capital sold 236,000 Co-Diagnostics shares in Q3 2026, an estimated $732K.
- Armistice Capital first reported a position in Co-Diagnostics in Q2 2026 and held it in 1 quarter.
- Armistice Capital's Co-Diagnostics position peaked at $732K in Q2 2026.
- 24 funds tracked by Wall St. Rank held Co-Diagnostics as of Q3 2026.
Based on Armistice Capital's 13F filing for Q3 2026, filed 16 Nov 2026.